BIOCON:NSE
Biocon Ltd
₹349.20
arrow_downward
-0.80%(-2.80) 1D
Okt 16, 3:30:00 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa BIOCON...
Buksan
₹352.60
Mataas
₹353.00
Mababa
₹348.00
Mkt. cap
568.79B
Avg. na dami
2.97M
Dami
1.88M
Dividend
0.14%
Bawat tatlong buwang dividend
₹0.12
Petsa ng ex-dividend
Hul 3, 2026
P/E ratio
103.38
Mataas nang 52-wk
₹447.15
Mababa nang 52-wk
₹337.70
EPS
₹3.38
Mga natitirang share
600.00M
Bilang ng mga empleyado
16K
Buksan
₹352.60
Mataas
₹353.00
Mababa
₹348.00
Mkt. cap
568.79B
Avg. na dami
2.97M
Dami
1.88M
Dividend
0.14%
Bawat tatlong buwang dividend
₹0.12
Petsa ng ex-dividend
Hul 3, 2026
P/E ratio
103.38
Mataas nang 52-wk
₹447.15
Mababa nang 52-wk
₹337.70
EPS
₹3.38
Mga natitirang share
600.00M
Bilang ng mga empleyado
16K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
MarketWatch
·
23 oras ang nakalipas
It was another great week for the average stock as market leadership shifts away from tech
investingLive
·
18 oras ang nakalipas
S&P 500 analysis and forecast after the "AI bubble" panic
Bloomberg.com
·
6 araw ang nakalipas
S&P 500 Wavers as Earnings Bets Offset Chip Rout: Markets Wrap
24/7 Wall St.
·
5 araw ang nakalipas
You Bought VOO to Own the S&P 500. On $500,000, One Chipmaker Is $40,400 of It
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Tungkol sa Biocon Ltd
CEOShreehas P Tambe
Mga Empleyado16.4K
ItinatagNob 29, 1978
HeadquartersBangalore, Karnataka, India
Sektor-
Websitebiocon.com